Tin protoporphyrin IX, a competitive HO-1 inhibitor, reduces CO production and suppresses excess HO-1-mediated bone resorption, effectively inhibiting bone loss in arthritis models (Ibáñez et al., 2011). This evidence concerns the gene HMOX1 and Arthritis.